Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab
Juan José Lerma Garrido; Antonio Gracia Pérez; Antonio Pérez Torres; Amalia Rueda Cid; Clara Molina Almela; María Dolores Pastor Cubillo; Cristina Campos Fernández; Isabel Balaguer Trull; Loreto Carmona; Javier Calvo Catalá;
Reumatol Clin. 2022;18:25-9
The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam
Hai-Binh Bui; Hong-Thinh Lai; Thanh-Lam Nguyen; Thuy-Duong Vu; Nhat-Le Bui; Van-Hung Nguyen; Thi-To-Chau Tran; Thi-Phuong-Thuy Nguyen; Thi-Ngoc-Lan Nguyen; Jaffar A. Al-Tawfiq; Dinh-Toi Chu;
Reumatol Clin. 2024;20:128-35
Evaluation of serum IgG4 levels as a screening tool for IgG4-related disease: Data from a retrospective study
Pablo Martínez Calabuig; Jorge Juan Fragío Gil; Roxana González Mazarío; Laura Salvador Maicas; Mireia Lucía Sanmartín Martínez; Antonio Sierra Rivera; Laura Abenza Barberá; María Cristina Sabater Abad; Francesc Puchades Gimeno; Inmaculada Castelló Miralles; Amalia Rueda Cid; Cristina Campos Fernández;
10.1016/j.reumae.2025.501852